000			01472 a2200385 4500
005			20250515053318.0
264		0	_c20080417
008			200804s 0 0 eng d
022			_a1530-6550
040			_aNLM _beng _cNLM
100	1		_aKandzari, David E
245	0	0	_aEvolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction. _h[electronic resource]
260			_bReviews in cardiovascular medicine _c2006
300			_aS29-37 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAngioplasty, Balloon, Coronary _xadverse effects
650	0	4	_aAnticoagulants _xadverse effects
650	0	4	_aBlood Platelets _xdrug effects
650	0	4	_aCardiovascular Diseases _xblood
650	0	4	_aClinical Trials as Topic
650	0	4	_aCombined Modality Therapy
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFibrinolysis _xdrug effects
650	0	4	_aFibrinolytic Agents _xadverse effects
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aMyocardial Infarction _xdrug therapy
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Aggregation Inhibitors _xadverse effects
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aResearch Design
650	0	4	_aTreatment Outcome
773	0		_tReviews in cardiovascular medicine _gvol. 7 Suppl 4 _gp. S29-37
999			_c16789548 _d16789548